Locked price vs escalating price
TMates vs Start Willow: Which Price Survives Titration? (2026)
Compare TMates and Start Willow on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.0 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
TMates and Start Willow both prescribe GLP-1 medication online, take payment directly from the patient and ship to the door. That is where the overlap stops.
The headline both platforms advertise is a month-one number. TMates keeps that number; Start Willow moves from $249 to $299, which is what actually determines the twelve-month bill.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest 12-month cost
- TMates — $2,388 against $3,538 at Start Willow, on each provider's own best published pricing.
- Most predictable bill
- TMates — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- Start Willow — The only one of the two that publishes a dual GIP/GLP-1 option.
- Most support included
- TMates — 24/7 access to U.S.-based doctors, not just messaging.
The short version: TMates vs Start Willow
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| TMates | Start Willow | |
|---|---|---|
| Advertised price | $199/mo at every dose, no step-up fees | From $249 the first month, then $299/mo |
| Rate after promotions | $199/mo | $299/mo |
| Pricing structure | Flat rate at every dose | Promotional first month, then standard rate |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Shipping | Medication formulated in U.S. facilities | Delivery guaranteed in 3 days or less |
| Support model | Provider check-ins included | No coaching program stated |
| Tirzepatide | Not published | Available |
| Price transparency | Published upfront | Published upfront |
| Patient reviews | 21,970 | 6,385 |
| eRxDoctor score | 7.0/10 | 7.0/10 |
The real cost: six months and twelve
The advertised rate answers the wrong question. So the table works in the timeframe treatment actually happens in.
| TMates | Start Willow | |
|---|---|---|
| First month | $199 | $249 |
| Months 2 onward | $199/mo | $299/mo |
| 6-month total | $1,194 | $1,744 |
| 12-month total | $2,388 | $3,538 |
| Best published plan | No multi-month discount published | No multi-month discount published |
TMates finishes the year $1,150 cheaper. For some patients the support Start Willow bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
What happens to the price as your dose goes up
Semaglutide and tirzepatide are titrated upward over the first months of treatment. Some providers price per milligram in all but name, so the invoice climbs alongside the dose; others hold one rate the whole way.
TMates is in the second group: one flat $199 that survives every titration step, with doctors rather than a message queue behind it. Start Willow is in the first — at $299 ongoing it is among the most expensive compounded programs here — which means the number you compared at signup is not the number you will be paying at month four.
The fix is one question at intake: what do I pay at maintenance dose? Everything else about pricing follows from that answer.
TMates in detail
$199/month, every dose, no step-up fees In this pairing, its distinguishing feature is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
From signup to first shipment: virtual check-in appointments, then medication formulated in U.S. facilities. Billing follows a flat rate at every dose structure.
What continues after the first shipment: 24/7 access to U.S.-based doctors, not just messaging. Formulary: compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- 24/7 access to U.S.-based doctors, not just messaging support
- Flat $199/month at every dose, no step-up fees as dosage escalates
- Medications formulated in U.S.-based facilities
TMates cons
- $199/month is higher than the cheapest compounded options
- Compounded semaglutide only, limited public detail on tirzepatide availability
- No branded Ozempic, Wegovy, or Zepbound
Set beside Start Willow, the thing to weigh: semaglutide only, and $199 is well above the cheapest compounded options.
How Start Willow works
The pitch is a delivery guarantee of three days or less and no membership stacked on the medication price. From $249 per Month
You start with fully online, no in-person visits; medication arrives via delivery guaranteed in 3 days or less. The price behaves as promotional first month, then standard rate.
Direct-pay model that bypasses insurance pre-authorization. The formulary covers compounded semaglutide and compounded tirzepatide.
Start Willow pros
- No insurance needed and no membership fees
- Medications comparable to Ozempic and tirzepatide
- Delivery guaranteed in 3 days or less
- Direct-pay model bypasses insurance pre-authorization entirely
Start Willow cons
- Ongoing $299/month is among the higher rates on this list
- Price rises from $249 first month to $299/month ongoing
- Compounded medication only, no branded Ozempic or Wegovy
Where it gives ground to TMates: at $299 ongoing it is among the most expensive compounded programs here.
TMates or Start Willow: matching the program to the patient
Choose TMates if:
- you want the price you sign up at to survive titration
- the monthly rate is the constraint — $199/mo against $299/mo
- the twelve-month total is what you are optimizing ($2,388 against $3,538)
- you are in a state where GLP-1 telehealth coverage is patchy
Choose Start Willow if:
- delivery works the way you want it to: delivery guaranteed in 3 days or less
- you want tirzepatide available without changing provider later
- you would get real value from a delivery guarantee of three days or less and no membership stacked on the medication price
- the level of clinical contact suits you: direct-pay model that bypasses insurance pre-authorization
Where each program concedes something
On price. $199/mo against $299/mo. Start Willow is asking you to pay for a delivery guarantee of three days or less and no membership stacked on the medication price; decide whether that is a line item you will use.
On predictability. Flat rate at every dose versus promotional first month, then standard rate. Whichever you pick, get the maintenance-dose price in writing at intake.
On access. TMates advertises virtual check-in appointments and medication formulated in U.S. facilities; Start Willow advertises fully online, no in-person visits and delivery guaranteed in 3 days or less. Coverage differs too — all 50 states against not published — which decides the question before price does if you are in a restricted state.
On medication. TMates covers compounded semaglutide; Start Willow covers compounded semaglutide and compounded tirzepatide. Only Start Willow publishes a tirzepatide route, which matters if semaglutide underdelivers.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither TMates nor Start Willow ran. Here is the source material, and what regulators say alongside it.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
TMates vs Start Willow: common questions
What happens when Start Willow's promotional price ends?
The rate moves to $299/mo, a 20% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Does the price go up as my dose increases?
At TMates, no — one flat $199 that survives every titration step, with doctors rather than a message queue behind it. At Start Willow, the published structure is promotional first month, then standard rate, moving from $249 to $299. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Which is cheaper to start, TMates or Start Willow?
TMates, at $199 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
How fast can I start with TMates compared with Start Willow?
TMates advertises virtual check-in appointments, with medication formulated in U.S. facilities. Start Willow advertises fully online, no in-person visits, with delivery guaranteed in 3 days or less. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do TMates or Start Willow take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, TMates or Start Willow?
TMates, with 21,970 against 6,385. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Is TMates or Start Willow better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis TMates has the stronger case; after month three, cost should take over.
The verdict
On the numbers, TMates wins the year: $2,388 against $3,538. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where Start Willow justifies itself is a delivery guarantee of three days or less and no membership stacked on the medication price. Where it does not is anywhere the extra spend buys features you will never open.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Enhance MD vs TMatesBudget vs premium
- Directmeds vs TMatesPublished price vs quote-only
- Start Willow vs MaximusBudget vs premium
- Mochi Health vs Start WillowBudget vs premium
- Yucca Health vs Sprout HealthLocked price vs escalating price
- Yucca Health vs IVIM HealthLocked price vs escalating price
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by TMates or Start Willow, and does not sell treatment. Read our ranking methodology.